Free Trial

Oncology Institute (TOI) Short Interest Ratio & Short Volume

Oncology Institute logo
$1.35 -0.09 (-6.25%)
Closing price 04:00 PM Eastern
Extended Trading
$1.36 +0.00 (+0.37%)
As of 06:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Oncology Institute Short Interest Data

Oncology Institute (TOI) has a short interest of 1.10 million shares, representing 2.99% of the float (the number of shares available for trading by the public). This marks a 2.80% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.4, indicating that it would take 1.4 days of the average trading volume of 723,243 shares to cover all short positions.

Current Short Interest
1,100,000 shares
Previous Short Interest
1,070,000 shares
Change Vs. Previous Month
+2.80%
Dollar Volume Sold Short
$718,300.00
Short Interest Ratio
1.4 Days to Cover
Last Record Date
March 15, 2025
Outstanding Shares
75,559,000 shares
Float Size
36,820,000 shares
Short Percent of Float
2.99%
Today's Trading Volume
638,517 shares
Average Trading Volume
723,243 shares
Today's Volume Vs. Average
88%
Short Selling Oncology Institute?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Oncology Institute and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TOI Short Interest Over Time

TOI Days to Cover Over Time

TOI Percentage of Float Shorted Over Time

Remove Ads

Oncology Institute Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/15/20251,100,000 shares $718,300.00 +2.8%3.0%1.4 $0.65
2/28/20251,070,000 shares $911,747.00 +14.5%2.9%0.9 $0.85
2/15/2025934,800 shares $898,436.28 +188.3%2.5%0.5 $0.96
1/31/2025324,300 shares $324,300.00 -7.6%0.9%0.2 $1.00
1/15/2025351,100 shares $140,440.00 +8.3%1.0%0.2 $0.40
12/31/2024324,100 shares $100,146.90 +86.8%0.9%0.2 $0.31
12/15/2024173,500 shares $38,673.15 -86.0%0.5%0.1 $0.22
11/30/20241,240,000 shares $200,880.00 +193.9%3.4%0.8 $0.16
11/15/2024421,900 shares $75,942.00 +70.1%1.1%0.4 $0.18
10/31/2024248,000 shares $76,880.00 -1.5%0.7%1.7 $0.31
10/15/2024251,800 shares $80,802.62 -0.3%0.8%2 $0.32
9/30/2024252,500 shares $82,542.25 +8.4%0.8%2 $0.33
9/15/2024233,000 shares $76,703.60 -22.8%0.7%1.8 $0.33
8/31/2024301,700 shares $108,853.36 +25.2%0.9%2.1 $0.36
8/15/2024240,900 shares $86,242.20 +9.6%0.7%1.4 $0.36
7/31/2024219,900 shares $120,065.40 -15.8%0.7%1.3 $0.55
7/15/2024261,000 shares $130,500.00 -13.5%0.8%1.5 $0.50
6/30/2024301,800 shares $138,828.00 +29.8%1.0%1.8 $0.46
6/15/2024232,600 shares $104,670.00 +13.2%0.7%1.3 $0.45
5/31/2024205,500 shares $101,558.10 -5.6%0.7%1.1 $0.49
5/15/2024217,600 shares $148,838.40 -18.9%0.7%1.3 $0.68
4/30/2024268,400 shares $284,504.00 +6.5%0.9%2.2 $1.06
4/15/2024252,000 shares $299,880.00 -4.1%0.8%2.2 $1.19
3/31/2024262,700 shares $415,066.00 +12.1%0.8%2.1 $1.58
3/15/2024234,300 shares $393,624.00 +3.8%0.8%1.7 $1.68
2/29/2024225,700 shares $424,316.00 -7.0%0.7%1.2 $1.88
2/15/2024242,600 shares $434,254.00 -20.8%0.8%1.1 $1.79
1/31/2024306,200 shares $627,710.00 -7.5%1.0%1.1 $2.05
1/15/2024330,900 shares $684,963.00 +20.3%0.8%1.1 $2.07
12/31/2023275,000 shares $561,000.00 +51.3%0.7%0.9 $2.04
12/15/2023181,800 shares $245,430.00 -35.0%0.7%0.6 $1.35
11/30/2023279,800 shares $478,458.00 -37.4%1.1%1 $1.71
11/15/2023447,000 shares $992,340.00 +91.3%1.7%1.8 $2.22
10/31/2023233,700 shares $446,367.00 -4.6%0.9%1 $1.91
10/15/2023245,000 shares $379,750.00 -8.8%0.9%1.2 $1.55
9/30/2023268,500 shares $375,900.00 +6.2%1.0%1 $1.40
9/15/2023252,900 shares $417,285.00 -11.9%1.0%0.9 $1.65
8/31/2023286,900 shares $332,804.00 -17.9%0.9%0.4 $1.16
8/15/2023349,300 shares $299,629.54 +42.0%1.1%0.4 $0.86
7/31/2023246,000 shares $240,440.40 -45.3%0.8%0.3 $0.98
Warning: “DOGE Collapse” imminent (Ad)

Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.

Click here to see what they’re predicting now.
7/15/2023450,000 shares $319,635.00 -7.3%1.4%0.5 $0.71
6/30/2023485,400 shares $267,067.08 -74.3%1.5%0.6 $0.55
6/15/20231,890,000 shares $1.14 million +39.0%6.0%2.4 $0.61
5/31/20231,360,000 shares $581,400.00 +5.4%4.4%2.1 $0.43
5/15/20231,290,000 shares $580,500.00 +1.6%4.1%6.6 $0.45
4/30/20231,270,000 shares $647,700.00 +5.8%4.1%7.4 $0.51
4/15/20231,200,000 shares $716,760.00 +2.6%3.9%6.9 $0.60
3/31/20231,170,000 shares $793,143.00 +13.6%3.8%7.2 $0.68
3/15/20231,030,000 shares $682,066.00 +12.0%3.5%5.7 $0.66
2/28/2023919,300 shares $1.30 million -21.4%3.2%6.7 $1.41
2/15/20231,170,000 shares $1.83 million -14.6%4.0%6.9 $1.56
1/31/20231,370,000 shares $2.03 million +31.7%4.7%7.1 $1.48
1/15/20231,040,000 shares $1.77 million +4.0%3.6%5.2 $1.70
12/30/20221,000,000 shares $1.65 million -8.3%3.8%5.1 $1.65
12/15/20221,090,000 shares $1.00 million +39.6%4.2%5.6 $0.92
11/30/2022780,600 shares $1.10 million -17.0%3.0%3.9 $1.41
11/15/2022940,500 shares $1.92 million -3.4%3.6%5.6 $2.04
10/31/2022973,100 shares $4.42 million -8.2%3.7%7 $4.54
10/15/20221,060,000 shares $4.71 million -18.5%4.1%8.4 $4.44
9/30/20221,300,000 shares $6.02 million +46.7%5.1%10.8 $4.63
9/15/2022886,100 shares $4.08 million -6.6%3.5%6 $4.61
8/31/2022948,900 shares $6.03 million +0.0%3.7%7.8 $6.35
8/15/2022948,700 shares $5.87 million +8.1%3.8%7.5 $6.19
7/31/2022878,000 shares $5.67 million -4.3%3.5%6.8 $6.46
7/15/2022917,000 shares $5.36 million +15.0%3.6%6.7 $5.84
6/30/2022797,600 shares $4.04 million +83.2%3.1%5.7 $5.06
6/15/2022435,400 shares $2.79 million -24.7%1.7%3.1 $6.40
5/31/2022578,100 shares $5.21 million +5.2%2.3%5.6 $9.01
5/15/2022549,300 shares $3.36 million -8.6%2.2%4.7 $6.12
4/30/2022600,800 shares $4.72 million +5.0%2.5%5.8 $7.86
4/15/2022572,000 shares $3.95 million +3.2%2.4%6.1 $6.90
3/31/2022554,100 shares $3.95 million +9.0%2.2%5.8 $7.13
3/15/2022508,500 shares $3.48 million -21.6%2.0%4.3 $6.84
2/28/2022648,800 shares $3.48 million +4.9%2.5%5.2 $5.37
2/15/2022618,500 shares $3.90 million 0.0%2.4%4.8 $6.31
1/31/2022618,700 shares $4.00 million +2.3%2.4%4.5 $6.46
1/15/2022605,100 shares $4.74 million +8.7%2.3%3.8 $7.83
12/31/2021556,500 shares $5.43 million No Change2.2%3.6 $9.75

TOI Short Interest - Frequently Asked Questions

What is Oncology Institute's current short interest?

Short interest is the volume of Oncology Institute shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 1,100,000 shares of TOI short. 2.99% of Oncology Institute's shares are currently sold short. Learn More on Oncology Institute's current short interest.

What is a good short interest ratio for Oncology Institute?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TOI shares currently have a short interest ratio of 1.0. Learn More on Oncology Institute's short interest ratio.

What is a good short interest percentage for Oncology Institute?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.99% of Oncology Institute's floating shares are currently sold short.

Is Oncology Institute's short interest increasing or decreasing?

Oncology Institute saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 1,100,000 shares, an increase of 2.8% from the previous total of 1,070,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Oncology Institute's float size?

Oncology Institute currently has issued a total of 75,559,000 shares. Some of Oncology Institute's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Oncology Institute currently has a public float of 36,820,000 shares.

How does Oncology Institute's short interest compare to its competitors?

2.99% of Oncology Institute's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Oncology Institute: Personalis, Inc. (6.41%), Viemed Healthcare, Inc. (0.93%), DocGo Inc. (7.54%), LifeMD, Inc. (23.61%), Sera Prognostics, Inc. (3.51%), AirSculpt Technologies, Inc. (30.53%), Quipt Home Medical Corp. (3.93%), Biodesix, Inc. (2.81%), EUDA Health Holdings Limited (0.06%), Exagen Inc. (0.20%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

What does it mean to sell short Oncology Institute stock?

Short selling TOI is an investing strategy that aims to generate trading profit from Oncology Institute as its price is falling. TOI shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Oncology Institute?

A short squeeze for Oncology Institute occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TOI, which in turn drives the price of the stock up even further.

How often is Oncology Institute's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TOI, twice per month. The most recent reporting period available is March, 15 2025.




This page (NASDAQ:TOI) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners